08:00 , Jan 5, 2015 |  BioCentury  |  Finance

4Q14 Stock Wrap-up: Grow early, grow often

Biotech stocks rose in 4Q14, with only the microcaps segment, with valuations under $200 million, finishing down. The rally followed two quarters in which only the large cap segment, with valuations over $5 billion, were...
08:00 , Nov 20, 2014 |  BC Innovations  |  Cover Story

Tapping TOPK

Although targeting proteins involved in cell division is falling out of fashion in cancer research because of the difficulty of distinguishing between diseased and normal cells, several companies are still exploring enzymes that could be...
08:00 , Nov 13, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Breast cancer; lung cancer PDZ binding kinase (PBK; TOPK) Mouse studies suggest a selective TOPK inhibitor could...